Forbes -
15 Aug 2014 19:42
Most of the company's major businesses are likely to sustain their growth momentum as new products have found good acceptance. We also expect gross margins to remain stable near 75% as Medtronic's cost saving efforts offset growing pricing pressures and product quality issues in some divisions.
Share this Article
Comment on this Article
Please to comment